Sygnature Discovery acquires Peak Proteins
Sygnature Discovery
APRIL 26, 2022
Integrated protein production in drug discovery Peak Proteins’s core technologies include protein expression and purification, alongside protein crystallography, structure determination and mass spectrometry services. Financial details of the transaction have not been disclosed.
Let's personalize your content